PHP
IRWD icon

Parkman Healthcare Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

Parkman Healthcare Partners’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-205,086
Closed -$301K – 93
2025
Q1 		$301K Sell
205,086
-203,449
-50% -$485K 0.04% 91
2024
Q4 		$1.81M Sell
408,535
-46,942
-10% -$190K 0.24% 77
2024
Q3 		$1.88M Sell
455,477
-420,791
-48% -$2.26M 0.24% 77
2024
Q2 		$5.71M Buy
876,268
+26,268
+3% +$186K 0.77% 46
2024
Q1 		$7.4M Buy
850,000
+729,348
+605% +$8.85M 0.91% 41
2023
Q4 		$1.38M Buy
120,652
+20,652
+21% +$204K 0.19% 75
2023
Q3 		$963K Buy
+100,000
New +$980K 0.18% 91

Other funds holding IRWD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Parkman Healthcare Partners's IRWD Position: Q2 2025 in Review

Parkman Healthcare Partners sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 205,086 shares — an estimated $301K sold.

Parkman Healthcare Partners first reported a position in IRWD in Q3 2023 and held it in 7 quarters. The position peaked at $7.4M in Q1 2024. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.

  • Parkman Healthcare Partners reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Parkman Healthcare Partners sold 205,086 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $301K.
  • Parkman Healthcare Partners first reported a position in Ironwood Pharmaceuticals in Q3 2023 and held it in 7 quarters.
  • Parkman Healthcare Partners's Ironwood Pharmaceuticals position peaked at $7.4M in Q1 2024.
  • 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.

Based on Parkman Healthcare Partners's 13F filing for Q2 2025, filed 14 Aug 2025.